MedTrace Logo

Lenstec Softec HD Posterior Chamber Intraocular Lens Clinical Investigational Protocol

NCT00963742 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 390

Last updated 2014-03-18

No results posted yet for this study

Summary

The objectives of this multi-center clinical investigation are to determine the safety and effectiveness of the Lenstec Softec HD Posterior Chamber intraocular lens (IOL) following one year of post-operative assessment.

Conditions

  • Cataract

Interventions

DEVICE

Lenstec Softec HD IOL implantation

surgical removal of cataract and implantation of Softec HD PCIOL

Sponsors & Collaborators

  • Lenstec Incorporated

    lead INDUSTRY

Principal Investigators

  • Donald R Sanders, M.D. Ph.D · Center for Clinical Research

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-12-31
Primary Completion
2009-07-31
Completion
2010-04-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00963742 on ClinicalTrials.gov